• Sales up 34% at €6,963 million, mainly due to higher prices
  • Considerable increase in EBIT before special items, primarily from stronger isocyanate margins

Sales to third parties in the Monomers division rose by €1,774 million to €6,963 million in 2017, largely as a result of higher prices. Robust demand and the temporary product shortages on the market led to a strong price increase, especially in the isocyanates business. Sales prices for polyamides also rose. We achieved year-on-year volumes growth with our new production facilities.

Monomers – Factors influencing sales
Chemicals – Monomers – Factors influencing sales (pie chart)
Monomers – Sales by region
(Location of customer)
Chemicals – Monomers – Sales by region (pie chart)

Stronger margins and volumes for isocyanates were the main reason for the considerable increase in EBIT before special items in the Monomers division. Earnings were also positively impacted by the restructuring of our caprolactam production in Europe. Fixed costs exceeded the prior-year level, mainly from our new production facilities.